← Open Payments lookup

ANNE KINGORI: Open Payments

NPI 1376230128 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,615 in 90 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $664 · 2025 $2,615

Food & beverage: $2,615
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$667
Axsome Therapeutics, Inc.11$452
Neurocrine BioSciences, Inc.10$352
ABBVIE INC.13$215
Alkermes, Inc.5$184
Otsuka America Pharmaceutical, Inc.11$168
E.R. Squibb & Sons, L.L.C.3$138
Teva Pharmaceuticals USA, Inc.4$137
Corium, LLC6$90
Noven Therapeutics, LLC2$43

Products named: CAPLYTA, Auvelity, INGREZZA, VRAYLAR, REXULTI, COBENFY, AUSTEDO XR, LYBALVI.

Industry payments across TX — which companies pay providers there.